{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:34:41Z","timestamp":1777671281273,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00228-020-03018-4","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T21:02:48Z","timestamp":1602968568000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"77","author":[{"given":"Sylvaine","family":"B\u0153uf-Gibot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kerroum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Menini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"De Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Vorilhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"Boussageon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3384-0335","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Vaillant-Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"issue":"3","key":"3018_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Pi\u00f1a IL, Trogdon JG, American Heart Association Advocacy Coordinating Committee, Council on Arteriosclerosis, Thrombosis and Vascular Biology., Council on Cardiovascular Radiology and Intervention., Council on Clinical Cardiology., Council on Epidemiology and Prevention., Stroke Council (2013) Forecasting the impact of heart failure in the United States : a policy statement from the American Heart Association. Circ Heart Fail 6(3):606\u2013619","journal-title":"Circ Heart Fail"},{"issue":"27","key":"3018_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"issue":"13","key":"3018_CR3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jama.2014.10186","volume":"312","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Montori VM, Del Mar C (2014) The connection between evidence-based medicine and shared decision making. JAMA 312(13):1295\u20131296","journal-title":"JAMA"},{"key":"3018_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450\u20131456","journal-title":"JAMA"},{"key":"3018_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2015.12.010","volume":"205","author":"W Xie","year":"2016","unstructured":"Xie W, Zheng F, Song X, Zhong B, Yan L (2016) Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: network meta-analysis. Int J Cardiol 205:65\u201371","journal-title":"Int J Cardiol"},{"key":"3018_CR6","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097 Available on: http:\/\/www.prisma-statement.org\/. Accessed 6 Feb 2020","DOI":"10.1371\/journal.pmed.1000097"},{"key":"3018_CR7","first-page":"8.1","volume-title":"Cochrane handbook for systematic review of interventions version 5.1.0","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Green S (2011) Chapter 8: assessing risk of bias in included studies. In: Higgins JP, Altman DG, Sterne JA (eds) Cochrane handbook for systematic review of interventions version 5.1.0. Wiley, Chichester, pp 8.1\u20138.53"},{"issue":"12","key":"3018_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, Williams JW Jr, Meerpohl J, Norris SL, Akl EA, Sch\u00fcnemann HJ (2011) GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol 64(12):1277\u20131282. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.01.011","journal-title":"J Clin Epidemiol"},{"key":"3018_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Sch\u00fcnemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3018_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","volume":"2","author":"PJ Cannon","year":"1983","unstructured":"Cannon PJ, Powers ER, Reison DS et al (1983) A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group. J Am Coll Cardiol 2(4):755\u2013763","journal-title":"J Am Coll Cardiol"},{"issue":"8875","key":"3018_CR11","first-page":"821","volume":"342","author":"AIRE Study Investigators","year":"1993","unstructured":"AIRE Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Lancet 342(8875):821\u2013828","journal-title":"Lancet"},{"issue":"10","key":"3018_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moy\u00e9 LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327(10):669\u2013677","journal-title":"N Engl J Med"},{"issue":"25","key":"3018_CR13","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L K\u00f8ber","year":"1995","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videb\u00e6k J, Cole DS, Auclert L, Pauly NC, Aliot E, Persson S, Camm AJ (1995) A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) study group. N Engl J Med 333(25):1670\u20131676","journal-title":"N Engl J Med"},{"issue":"6","key":"3018_CR14","first-page":"351","volume":"43","author":"P Jerie","year":"1997","unstructured":"Jerie P, Kremer HJ, Uhl\u00edr O, Widimsk\u00fd J (1997) A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure. Vnitr Lek 43(6):351\u2013358","journal-title":"Vnitr Lek"},{"issue":"5","key":"3018_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"SOLVD Investigators","year":"1991","unstructured":"Investigators SOLVD, Yusuf S, Pitt B et al (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325(5):293\u2013302","journal-title":"N Engl J Med"},{"issue":"10","key":"3018_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"SOLVD Investigators","year":"1992","unstructured":"Investigators SOLVD, Yusuf S, Pitt B et al (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327(10):685\u2013691","journal-title":"N Engl J Med"},{"issue":"23","key":"3018_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316(23):1429\u20131435","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"3018_CR18","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1097\/00005344-198700003-00021","volume":"9","author":"JP Chalmers","year":"1987","unstructured":"Chalmers JP, West MJ, Cyran J, la Torre DD, Englert M, Kramar M, Lewis GRJ, Maranhao MFL, Myburgh DP, Schuster P, Sialer S, Simon H, Stephens JD, Watson RDS (1987) Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study. J Cardiovasc Pharmacol 9(Suppl 3):S89\u2013S97","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"3018_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0002-9149(99)80624-9","volume":"75","author":"EJ Brown","year":"1995","unstructured":"Brown EJ, Chew PH, MacLean A et al (1995) Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. Am J Cardiol 75(8):596\u2013600","journal-title":"Am J Cardiol"},{"issue":"12","key":"3018_CR20","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/oxfordjournals.eurheartj.a060844","volume":"16","author":"L Erhardt","year":"1995","unstructured":"Erhardt L, MacLean A, Ilgenfritz J et al (1995) Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy\/Safety Trial (FEST) study group. Eur Heart J 16(12):1892\u20131899","journal-title":"Eur Heart J"},{"key":"3018_CR21","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1472-6947-13-S2-S5","volume":"13","author":"VM Montori","year":"2013","unstructured":"Montori VM, Leblanc A, Buchholz A et al (2013) Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards [Internet]. BMC Med Inform Decis Mak 13:S5","journal-title":"BMC Med Inform Decis Mak"},{"issue":"10","key":"3018_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jama.2014.9263","volume":"312","author":"ML Rethlefsen","year":"2014","unstructured":"Rethlefsen ML, Murad MH, Livingston EH (2014) Engaging medical librarians to improve the quality of review articles. JAMA 312(10):999\u20131000. https:\/\/doi.org\/10.1001\/jama.2014.9263","journal-title":"JAMA"},{"key":"3018_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jclinepi.2014.12.017","volume":"68","author":"CW Halladay","year":"2015","unstructured":"Halladay CW, Trikalinos TA, Schmid IT, Schmid CH, Dahabreh IJ (2015) Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions. J Clin Epidemiol 68:1076\u20131084","journal-title":"J Clin Epidemiol"},{"key":"3018_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jclinepi.2016.04.002","volume":"79","author":"A Booth","year":"2016","unstructured":"Booth A (2016) Over 85% of included studies in systematic reviews are on Medline. J Clin Epidemiol 79:165\u2013166","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3018_CR25","doi-asserted-by":"publisher","first-page":"e0212907","DOI":"10.1371\/journal.pone.0212907","volume":"14","author":"RD Turgeon","year":"2019","unstructured":"Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP (2019) Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: systematic review and meta-analysis. PLoS One 14(2):e0212907","journal-title":"PLoS One"},{"key":"3018_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1234","volume":"20","author":"M Komajda","year":"2018","unstructured":"Komajda M, B\u00f6hm M, Borer JS et al (2018) Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis. Eur J Heart Fail 20:1315\u20131322","journal-title":"Eur J Heart Fail"},{"issue":"7650","key":"3018_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ, GRADE Working Group (2008) GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","journal-title":"BMJ"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03018-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-03018-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03018-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:41:08Z","timestamp":1634431268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-03018-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3018"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-03018-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,17]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not necessary for this study because only de-identified pooled data from individual studies were analysed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}